Active Filters

  • (-) Journals = ACS Chemical Neuroscience
  • (-) Keywords ≠ Alzheimer's disease
Search Results 1 - 5 of 5
  • RSS Feed
Select Page
Channel activities of the full-length prion and truncated proteins
Wu, J., Wang, X., Lakkaraju, A., Sternke-Hoffmann, R., Qureshi, B. M., Aguzzi, A., & Luo, J. (2024). Channel activities of the full-length prion and truncated proteins. ACS Chemical Neuroscience, 15(1), 98-107. https://doi.org/10.1021/acschemneuro.3c00412
Elucidation of the GSK3α structure informs the design of novel, paralog-selective inhibitors
Amaral, B., Capacci, A., Anderson, T., Tezer, C., Bajrami, B., Lulla, M., … Koirala, S. (2023). Elucidation of the GSK3α structure informs the design of novel, paralog-selective inhibitors. ACS Chemical Neuroscience, 14(6), 1080-1094. https://doi.org/10.1021/acschemneuro.2c00476
Novel macrocyclic antagonists of the calcitonin gene-related peptide receptor: design, realization, and structural characterization of protein-ligand complexes
Cansfield, A. D., Ator, M. A., Banerjee, J., Bestwick, M., Bortolato, A., Brown, G. A., … Watson, S. P. (2022). Novel macrocyclic antagonists of the calcitonin gene-related peptide receptor: design, realization, and structural characterization of protein-ligand complexes. ACS Chemical Neuroscience, 13(6), 751-765. https://doi.org/10.1021/acschemneuro.1c00696
Inhibition of 14-3-3/Tau by hybrid small-molecule peptides operating via two different binding modes
Andrei, S. A., Meijer, F. A., Neves, J. F., Brunsveld, L., Landrieu, I., Ottmann, C., & Milroy, L. G. (2018). Inhibition of 14-3-3/Tau by hybrid small-molecule peptides operating via two different binding modes. ACS Chemical Neuroscience, 9(11), 2639-2654. https://doi.org/10.1021/acschemneuro.8b00118
Comparative analysis of the neurochemical profile and MAO inhibition properties of N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine
De Deurwaerdère, P., Binda, C., Corne, R., Leone, C., Valeri, A., Valoti, M., … Marco-Contelles, J. (2017). Comparative analysis of the neurochemical profile and MAO inhibition properties of N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine. ACS Chemical Neuroscience, 8(5), 1026-1035. https://doi.org/10.1021/acschemneuro.6b00377